2024-06-30 false--12-31 2024 Q2 0001756594 0001756594 2024-01-01 2024-06-30 0001756594 iva:LongTermFinancialDebtDerivativesMember iva:WarrantAgreementWithEuropeanInvestmentBankMember 2022-11-28 2022-11-28 0001756594 iva:DavidNikodemMember iva:Bsa20232ShareWarrantPlanMember 2023-12-31 0001756594 iva:DavidNikodemMember iva:Bsa20231ShareWarrantPlanMember 2023-12-31 0001756594 iva:DavidNikodemMember iva:BsaShareWarrantsMember 2021-12-31 0001756594 iva:DavidNikodemMember iva:BsaShareWarrantsMember 2020-12-31 0001756594 iva:DavidNikodemMember iva:BsaShareWarrantsMember 2019-12-31 0001756594 iva:ServiceProvidersMember iva:BsaShareWarrantsMember 2018-12-31 0001756594 iva:DirectorsMember iva:BsaShareWarrantsMember 2017-12-31 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember 2024-01-01 2024-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember 2023-01-01 2023-12-31 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember 2022-11-28 2022-11-28 0001756594 ifrs-full:TopOfRangeMember iva:Nativ3PhaseIiiClinicalTrialWithLanifibranorInPatientsWithMashNashMember 2024-05-16 2024-05-16 0001756594 ifrs-full:BottomOfRangeMember iva:Nativ3PhaseIiiClinicalTrialWithLanifibranorInPatientsWithMashNashMember 2024-05-16 2024-05-16 0001756594 iva:WarrantAgreementWithEuropeanInvestmentBankMember 2022-07-01 2022-07-01 0001756594 iva:LongTermFinancialDebtDerivativesMember iva:WarrantAgreementWithEuropeanInvestmentBankMember 2022-07-01 0001756594 iva:IssuanceOfSharesOrWarrantsWithoutPreferentialSubscriptionRightsMember 2024-10-14 2024-10-14 0001756594 iva:RoyaltyCertificatesLiabilitiesMember 2024-01-01 2024-06-30 0001756594 iva:LicensingAgreementWithHepalysMember iva:HepalysPharmaIncMember 2023-10-11 2023-10-11 0001756594 iva:FinancingThroughFundRaisingMember iva:LicensingAndCollaborationAgreementWithCttqMember iva:ScenarioTwoMember 2024-10-11 2024-10-11 0001756594 iva:FinancingThroughFundRaisingMember iva:LicensingAndCollaborationAgreementWithCttqMember iva:ScenarioThreeMember 2024-10-11 2024-10-11 0001756594 iva:FinancingThroughFundRaisingMember iva:LicensingAndCollaborationAgreementWithCttqMember iva:ScenarioOneMember 2024-10-11 2024-10-11 0001756594 iva:FinanceContractWithEuropeanInvestmentBankMember 2024-06-30 0001756594 iva:PresentationOfResultsFromStudyMember iva:Nativ3PhaseIiiClinicalTrialWithLanifibranorInPatientsWithMashNashMember 2024-07-05 0001756594 iva:LoanAgreementsWithSyndicateOfFrenchBanksStateGuaranteedLoanPretGarantiParLetatMember 2022-01-01 2022-12-31 0001756594 iva:LicensingAndCollaborationAgreementWithCttqMember 2023-06-30 0001756594 iva:ServiceContractWithAvantSanteMember 2023-06-30 0001756594 iva:LicensingAgreementWithHepalysMember iva:HepalysPharmaIncMember 2023-09-26 0001756594 iva:Nativ3PhaseIiiTrialOfLanifibranorInNonCirrhoticNashMember 2024-03-07 0001756594 iva:FredericCrenMember iva:LongTermIncentivePlanInPerformanceUnits2023Member 2024-03-25 0001756594 iva:HepalysPharmaIncMember 2023-10-11 2023-10-11 0001756594 iva:LongTermIncentivePlanInPerformanceUnitsMember 2024-01-01 0001756594 ifrs-full:BottomOfRangeMember iva:PhaseIiClinicalTrialEvaluatingPlaceboInPatientsWithMashNashAndT2dMember 2024-05-16 0001756594 iva:PhaseIiClinicalTrialEvaluatingPlaceboInPatientsWithMashNashAndT2dMember 2024-05-16 0001756594 iva:LegendPhaseIiaCombinationTrialWithLanifibranorAndEmpagliflozinInPatientsWithMashNashAndT2dMember 2024-03-18 0001756594 iva:LoanAgreementsWithSyndicateOfFrenchBanksUnderStimulusEconomicPlanMember 2022-06-01 2022-06-30 0001756594 iva:LoanAgreementsWithSyndicateOfFrenchBanksStateGuaranteedLoanPretGarantiParLetatMember 2022-06-01 2022-06-30 0001756594 iva:FinancingFromSyndicateOfFrenchBanksMember 2022-06-01 2022-06-30 0001756594 iva:FinancingAgreementInThreePhasesMember 2024-01-01 2024-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankMember 2022-05-16 2022-05-16 0001756594 iva:IndicationOfContinuationOfRecruitmentForPhaseIiiTrialNativ3OfLanifibranorInNonCirrhoticNashashMember 2024-02-01 2024-02-01 0001756594 iva:ContractCroWithPharmaceuticalResearchAssociatesB.vMember 2024-06-30 0001756594 iva:ContractCroWithPharmaceuticalResearchAssociatesB.vMember 2023-12-31 0001756594 iva:FinancingThroughFundRaisingMember iva:LicensingAndCollaborationAgreementWithCttqMember 2024-10-11 2024-10-11 0001756594 iva:IssuanceOfRoyaltyCertificatesMember 2024-07-18 2024-07-18 0001756594 iva:IndicationOfContinuationOfRecruitmentForPhaseIiiTrialNativ3OfLanifibranorInNonCirrhoticNashashMember 2023-01-01 2023-01-31 0001756594 iva:IndicationOfContinuationOfRecruitmentForPhaseIiiTrialNativ3OfLanifibranorInNonCirrhoticNashashMember 2022-01-01 2022-12-31 0001756594 2024-01-01 2024-01-01 0001756594 2023-01-01 2023-01-01 0001756594 2019-01-01 2019-12-31 0001756594 iva:LicensingAgreementWithHepalysMember 2023-10-18 0001756594 iva:FibroscanMachinesMember ifrs-full:TopOfRangeMember 2024-01-01 2024-06-30 0001756594 iva:FibroscanMachinesMember ifrs-full:BottomOfRangeMember 2024-01-01 2024-06-30 0001756594 ifrs-full:RightofuseAssetsMember 2024-01-01 2024-06-30 0001756594 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2024-01-01 2024-06-30 0001756594 ifrs-full:SharePremiumMember 2024-01-01 2024-06-30 0001756594 ifrs-full:IssuedCapitalMember 2024-01-01 2024-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember iva:DrawdownOfBorrowingsMember 2024-01-18 2024-01-18 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember 2024-01-18 2024-01-18 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember 2022-12-08 2022-12-08 0001756594 iva:IssuanceOfSharesOrWarrantsSubjectToConditionsMember 2024-10-14 2024-10-14 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember iva:WarrantAgreementWithEuropeanInvestmentBankMember 2024-06-30 0001756594 ifrs-full:OrdinarySharesMember iva:WarrantAgreementWithEuropeanInvestmentBankMember 2023-12-31 0001756594 iva:IssuanceOfSharesOrWarrantsSubjectToConditionsMember 2024-10-14 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember iva:LongTermFinancialDebtDerivativesMember iva:WarrantAgreementWithEuropeanInvestmentBankMember 2024-01-04 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember 2024-01-03 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember iva:LongTermFinancialDebtDerivativesMember iva:WarrantAgreementWithEuropeanInvestmentBankMember 2022-11-28 0001756594 iva:EquityRecoveryLoansMember 2023-05-01 2023-05-31 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember 2024-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember 2024-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember 2024-01-04 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember 2023-12-31 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember 2022-11-28 0001756594 iva:PhaseIiClinicalTrialEvaluatingPlaceboInPatientsWithMashNashAndT2dMember 2024-03-18 2024-03-18 0001756594 iva:PhaseIiClinicalTrialEvaluatingLanifibranorInPatientsWithT2dAndNonalcoholicFattyLiverDiseaseMember 2024-03-18 2024-03-18 0001756594 iva:LegendPhaseIiaCombinationTrialWithLanifibranorAndEmpagliflozinInPatientsWithMashNashAndT2dMember 2024-03-18 2024-03-18 0001756594 iva:ChiaTaiTianqingMember 2024-06-30 0001756594 iva:ContractCroWithResearchAssociatesGroupeB.vMember 2021-04-30 0001756594 ifrs-full:TopOfRangeMember iva:PharmaceuticalResearchAssociatesMember 2024-01-01 2024-06-30 0001756594 ifrs-full:BottomOfRangeMember iva:PharmaceuticalResearchAssociatesMember 2024-01-01 2024-06-30 0001756594 iva:WarrantAgreementWithEuropeanInvestmentBankMember 2024-01-04 2024-01-04 0001756594 iva:LongTermFinancialDebtDerivativesMember iva:WarrantAgreementWithEuropeanInvestmentBankMember 2022-07-01 2022-07-01 0001756594 iva:IssuanceOfSharesWithoutPreferentialSubscriptionRightsMember 2024-10-14 2024-10-14 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember iva:LongTermFinancialDebtDerivativesMember iva:WarrantAgreementWithEuropeanInvestmentBankMember 2024-01-04 2024-01-04 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember iva:LongTermFinancialDebtDerivativesMember iva:WarrantAgreementWithEuropeanInvestmentBankMember 2022-11-28 2022-11-28 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember 2024-01-03 2024-01-03 0001756594 iva:IssuanceOfRoyaltyCertificatesMember 2024-07-18 0001756594 iva:LicensingAndCollaborationAgreementWithCttqMember 2024-01-18 2024-01-18 0001756594 iva:FinancingAgreementInThreePhasesMember 2024-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember 2024-01-18 0001756594 iva:Bsa2024Member 2024-06-30 0001756594 iva:Bsa2022Member 2024-06-30 0001756594 iva:DavidNikodemMember iva:Bsa20232ShareWarrantPlanMember 2023-01-01 2023-12-31 0001756594 iva:DavidNikodemMember iva:Bsa20231ShareWarrantPlanMember 2023-01-01 2023-12-31 0001756594 ifrs-full:NotLaterThanThreeMonthsMember 2024-06-30 0001756594 ifrs-full:NotLaterThanThreeMonthsMember 2023-12-31 0001756594 iva:LaterThanTwoMonthsMember 2024-06-30 0001756594 ifrs-full:NotLaterThanOneMonthMember 2024-06-30 0001756594 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2024-06-30 0001756594 ifrs-full:NotLaterThanOneMonthMember 2023-12-31 0001756594 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2023-12-31 0001756594 2024-01-01 2024-12-31 0001756594 iva:RoyaltyCertificatesLiabilitiesMember ifrs-full:DiscountRateMeasurementInputMember 2024-06-30 0001756594 iva:FinancingFromSyndicateOfFrenchBanksMember 2024-01-01 2024-06-30 0001756594 iva:InventivaIncMember 2024-01-01 2024-06-30 0001756594 iva:HepalysPharmaIncMember 2024-01-01 2024-06-30 0001756594 iva:HepalysPharmaIncMember 2023-01-01 2023-12-31 0001756594 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2024-06-30 0001756594 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-12-31 0001756594 iva:HepalysPharmaIncMember 2024-01-15 2024-01-15 0001756594 iva:FinanceContractWithEuropeanInvestmentBankMember 2024-01-18 2024-01-18 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember 2024-01-04 2024-01-04 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember 2024-01-01 2024-06-30 0001756594 iva:FinancingFromSyndicateOfFrenchBanksMember 2020-05-01 2020-05-31 0001756594 iva:IssuanceOfSharesWithoutPreferentialSubscriptionRightsMember 2024-10-14 0001756594 iva:IssuanceOfSharesOrWarrantsWithoutPreferentialSubscriptionRightsMember 2024-10-14 0001756594 ifrs-full:IssuedCapitalMember 2024-03-25 0001756594 iva:LicensingAndCollaborationAgreementWithCttqMember 2023-12-31 0001756594 iva:HepalysPharmaIncMember 2023-01-01 2023-12-31 0001756594 iva:NewBonusShareAwardPlan20232Member 2024-06-30 0001756594 iva:NewBonusShareAwardPlan20231Member 2024-06-30 0001756594 iva:Bsa20232ShareWarrantPlanMember 2024-06-30 0001756594 iva:Bsa20231ShareWarrantPlanMember 2024-06-30 0001756594 iva:BonusShareAwardPlansMember 2024-06-30 0001756594 iva:NewShareWarrantPlansBsa2019TerMember 2023-12-31 0001756594 iva:NewShareWarrantPlansBsa2019Member 2023-12-31 0001756594 iva:NewShareWarrantPlansBsa2019BisMember 2023-12-31 0001756594 iva:NewBsa2021ShareWarrantPlanMember 2023-12-31 0001756594 iva:NewBonusShareAwardPlanAga2021BisMember 2023-12-31 0001756594 iva:NewBonusShareAwardPlanAga20211Member 2023-12-31 0001756594 iva:NewBonusShareAwardPlan20232Member 2023-12-31 0001756594 iva:NewBonusShareAwardPlan20231Member 2023-12-31 0001756594 iva:LongTermIncentivePlanInPerformanceUnitsMember 2023-12-31 0001756594 iva:LongTermIncentivePlanInPerformanceUnits2023Member 2023-12-31 0001756594 iva:BspcePlansMember 2023-12-31 0001756594 iva:BspceAndBsaShareWarrantsMember 2023-12-31 0001756594 iva:Bspce2021PlanMember 2023-12-31 0001756594 iva:BsaPlansMember 2023-12-31 0001756594 iva:Bsa20232ShareWarrantPlanMember 2023-12-31 0001756594 iva:Bsa20231ShareWarrantPlanMember 2023-12-31 0001756594 iva:Bsa2018PlanMember 2023-12-31 0001756594 iva:Bsa2017PlanMember 2023-12-31 0001756594 iva:BonusShareAwardPlansMember 2023-12-31 0001756594 iva:NewBonusShareAwardPlan20232Member 2024-01-01 2024-06-30 0001756594 iva:LongTermIncentivePlanInPerformanceUnitsMember 2024-01-01 2024-06-30 0001756594 iva:FredericCrenMember iva:LongTermIncentivePlanInPerformanceUnits2023Member 2024-03-25 2024-03-25 0001756594 iva:NewBonusShareAwardPlanAga2021BisMember 2024-01-01 2024-06-30 0001756594 iva:NewBonusShareAwardPlanAga20211Member 2024-01-01 2024-06-30 0001756594 iva:NewShareWarrantPlansBsa2019TerMember 2024-06-30 0001756594 iva:NewShareWarrantPlansBsa2019Member 2024-06-30 0001756594 iva:NewShareWarrantPlansBsa2019BisMember 2024-06-30 0001756594 iva:NewBsa2021ShareWarrantPlanMember 2024-06-30 0001756594 iva:BspcePlansMember 2024-06-30 0001756594 iva:BspceAndBsaShareWarrantsMember 2024-06-30 0001756594 iva:Bspce2021PlanMember 2024-06-30 0001756594 iva:BsaPlansMember 2024-06-30 0001756594 iva:Bsa2018PlanMember 2024-06-30 0001756594 iva:Bsa2017PlanMember 2024-06-30 0001756594 iva:Bsa2024Member 2024-01-01 2024-06-30 0001756594 iva:Bsa2022Member 2024-01-01 2024-06-30 0001756594 iva:BonusShareAwardPlansMember 2024-01-01 2024-06-30 0001756594 iva:InventivaS.aMember 2024-06-30 0001756594 iva:InventivaIncMember 2024-06-30 0001756594 iva:InventivaS.aMember 2023-06-30 0001756594 iva:InventivaIncMember 2023-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2024-01-18 0001756594 2024-01-18 0001756594 iva:LoanAgreementsWithSyndicateOfFrenchBanksUnderStimulusEconomicPlanMember 2022-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankMember 2022-05-16 0001756594 iva:InventivaIncMember 2024-06-30 0001756594 ifrs-full:SharePremiumMember 2024-03-25 2024-03-25 0001756594 ifrs-full:IssuedCapitalMember 2024-03-25 2024-03-25 0001756594 ifrs-full:AccumulatedImpairmentMember 2024-06-30 0001756594 ifrs-full:AccumulatedImpairmentMember 2023-12-31 0001756594 iva:FinanceContractWithEuropeanInvestmentBankMember 2024-01-01 2024-06-30 0001756594 ifrs-full:GrossCarryingAmountMember 2024-06-30 0001756594 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2024-06-30 0001756594 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001756594 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2023-12-31 0001756594 iva:Aga2021Aga2021BisMember 2024-01-01 2024-06-30 0001756594 2024-03-25 2024-03-25 0001756594 iva:InventivaIncMember 2024-01-01 2024-06-30 0001756594 iva:HepalysPharmaIncMember 2024-06-30 0001756594 iva:HepalysPharmaIncMember 2023-12-31 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember ifrs-full:FinancialLiabilitiesAtFairValueMember 2024-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember ifrs-full:FinancialLiabilitiesAtFairValueMember 2024-06-30 0001756594 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember iva:LongTermFinancialDebtDerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2024-06-30 0001756594 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember ifrs-full:ShorttermBorrowingsMember 2024-06-30 0001756594 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember ifrs-full:LongtermBorrowingsMember 2024-06-30 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2024-06-30 0001756594 iva:TradePayablesMember 2024-06-30 0001756594 iva:RoyaltyCertificatesLiabilitiesMember 2024-06-30 0001756594 iva:OtherMiscellaneousPayablesMember 2024-06-30 0001756594 iva:DerivativeInstrumentsMember 2024-06-30 0001756594 ifrs-full:ShorttermBorrowingsMember 2024-06-30 0001756594 ifrs-full:LongtermBorrowingsMember 2024-06-30 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2024-06-30 0001756594 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember iva:LongTermFinancialDebtDerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001756594 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001756594 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember iva:TradePayablesMember 2023-12-31 0001756594 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember iva:RoyaltyCertificatesLiabilitiesMember 2023-12-31 0001756594 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember iva:OtherMiscellaneousPayablesMember 2023-12-31 0001756594 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember ifrs-full:ShorttermBorrowingsMember 2023-12-31 0001756594 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember ifrs-full:LongtermBorrowingsMember 2023-12-31 0001756594 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember iva:DerivativeInstrumentsMember 2023-12-31 0001756594 iva:TradePayablesMember 2023-12-31 0001756594 iva:RoyaltyCertificatesLiabilitiesMember 2023-12-31 0001756594 iva:OtherMiscellaneousPayablesMember 2023-12-31 0001756594 iva:DerivativeInstrumentsMember 2023-12-31 0001756594 ifrs-full:ShorttermBorrowingsMember 2023-12-31 0001756594 ifrs-full:LongtermBorrowingsMember 2023-12-31 0001756594 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2023-12-31 0001756594 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember 2023-12-31 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember iva:OtherReceivablesMember 2024-06-30 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember iva:IfrsCashAndCashEquivalentsMember 2024-06-30 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember iva:AdvancePaymentMember 2024-06-30 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember iva:AccruedIncomeMember 2024-06-30 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember ifrs-full:TradeReceivablesMember 2024-06-30 0001756594 iva:OtherReceivablesMember 2024-06-30 0001756594 iva:IfrsCashAndCashEquivalentsMember 2024-06-30 0001756594 iva:AdvancePaymentMember 2024-06-30 0001756594 iva:AccruedIncomeMember 2024-06-30 0001756594 ifrs-full:TradeReceivablesMember 2024-06-30 0001756594 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember 2024-06-30 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember iva:ShortTermDepositAccountsMember 2023-12-31 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember iva:OtherReceivablesMember 2023-12-31 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember iva:LongTermSecurityDepositsMember 2023-12-31 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember iva:LongTermDepositAccountsMember 2023-12-31 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember iva:IfrsCashAndCashEquivalentsMember 2023-12-31 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember iva:AdvancePaymentMember 2023-12-31 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember ifrs-full:TradeReceivablesMember 2023-12-31 0001756594 iva:ShortTermDepositAccountsMember 2023-12-31 0001756594 iva:OtherReceivablesMember 2023-12-31 0001756594 iva:LongTermSecurityDepositsMember 2023-12-31 0001756594 iva:LongTermDepositAccountsMember 2023-12-31 0001756594 iva:IfrsCashAndCashEquivalentsMember 2023-12-31 0001756594 iva:AdvancePaymentMember 2023-12-31 0001756594 ifrs-full:TradeReceivablesMember 2023-12-31 0001756594 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2023-12-31 0001756594 iva:NewBonusShareAwardPlan20231Member 2023-01-01 2023-06-30 0001756594 iva:RetainedEarningsExcludingProfitLossFromCurrentReportingPeriodAndTreasurySharesMember 2024-06-30 0001756594 ifrs-full:SharePremiumMember 2024-06-30 0001756594 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 2024-06-30 0001756594 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-06-30 0001756594 ifrs-full:IssuedCapitalMember 2024-06-30 0001756594 iva:RetainedEarningsExcludingProfitLossFromCurrentReportingPeriodAndTreasurySharesMember 2023-12-31 0001756594 ifrs-full:SharePremiumMember 2023-12-31 0001756594 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 2023-12-31 0001756594 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001756594 ifrs-full:IssuedCapitalMember 2023-12-31 0001756594 iva:RetainedEarningsExcludingProfitLossFromCurrentReportingPeriodAndTreasurySharesMember 2023-06-30 0001756594 ifrs-full:SharePremiumMember 2023-06-30 0001756594 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 2023-06-30 0001756594 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-06-30 0001756594 ifrs-full:IssuedCapitalMember 2023-06-30 0001756594 iva:RetainedEarningsExcludingProfitLossFromCurrentReportingPeriodAndTreasurySharesMember 2022-12-31 0001756594 iva:HepalysPharmaIncMember 2022-12-31 0001756594 ifrs-full:SharePremiumMember 2022-12-31 0001756594 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 2022-12-31 0001756594 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-12-31 0001756594 ifrs-full:IssuedCapitalMember 2022-12-31 0001756594 iva:IfrsSalesAndMarketingExpenseMember 2024-01-01 2024-06-30 0001756594 iva:IfrsResearchAndDevelopmentExpenseMember 2024-01-01 2024-06-30 0001756594 iva:IfrsGeneralAndAdministrativeExpenseMember 2024-01-01 2024-06-30 0001756594 iva:IfrsSalesAndMarketingExpenseMember 2023-01-01 2023-06-30 0001756594 iva:IfrsResearchAndDevelopmentExpenseMember 2023-01-01 2023-06-30 0001756594 iva:IfrsGeneralAndAdministrativeExpenseMember 2023-01-01 2023-06-30 0001756594 iva:NewBonusShareAwardPlan20231Member 2024-01-01 2024-06-30 0001756594 iva:LongTermIncentivePlanInPerformanceUnits2023Member 2024-01-01 2024-06-30 0001756594 iva:BspceAndBsaShareWarrantsMember 2024-01-01 2024-06-30 0001756594 iva:LicensingAndCollaborationAgreementWithCttqMember 2024-06-30 0001756594 iva:PharmaceuticalResearchAssociatesMember 2024-06-30 0001756594 iva:ContractManufacturingOrganizationsMember 2024-06-30 0001756594 iva:ContractCroWithResearchAssociatesGroupeB.vMember 2024-06-30 0001756594 iva:ClinicalTrialsMember 2024-06-30 0001756594 ifrs-full:OtherContingentLiabilitiesMember 2024-06-30 0001756594 ifrs-full:LeaseLiabilitiesMember 2024-06-30 0001756594 iva:ContractManufacturingOrganizationsMember 2023-12-31 0001756594 iva:ClinicalTrialsMember 2023-12-31 0001756594 ifrs-full:OtherContingentLiabilitiesMember 2023-12-31 0001756594 ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001756594 iva:RetainedEarningsExcludingProfitLossFromCurrentReportingPeriodAndTreasurySharesMember 2024-01-01 2024-06-30 0001756594 iva:HepalysPharmaIncMember 2024-01-01 2024-06-30 0001756594 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 2024-01-01 2024-06-30 0001756594 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-01-01 2024-06-30 0001756594 iva:RetainedEarningsExcludingProfitLossFromCurrentReportingPeriodAndTreasurySharesMember 2023-01-01 2023-06-30 0001756594 ifrs-full:RetainedEarningsProfitLossForReportingPeriodMember 2023-01-01 2023-06-30 0001756594 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-01-01 2023-06-30 0001756594 2023-06-30 0001756594 ifrs-full:LeaseLiabilitiesMember ifrs-full:TopOfRangeMember 2024-06-30 0001756594 ifrs-full:LeaseLiabilitiesMember ifrs-full:BottomOfRangeMember 2024-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember iva:DrawdownOfBorrowingsMember 2024-01-18 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember 2024-01-18 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember 2022-12-08 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2024-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2024-06-30 0001756594 iva:RoyaltyCertificatesLiabilitiesMember 2024-06-30 0001756594 ifrs-full:NotLaterThanOneYearMember 2024-06-30 0001756594 ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2024-06-30 0001756594 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2024-06-30 0001756594 ifrs-full:LaterThanFiveYearsMember 2024-06-30 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2023-12-31 0001756594 iva:RoyaltyCertificatesLiabilitiesMember 2023-12-31 0001756594 ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001756594 ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001756594 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2023-12-31 0001756594 ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001756594 iva:RoyaltyCertificateLiabilitiesMember 2023-08-31 0001756594 2022-12-31 0001756594 iva:FinanceContractWithEuropeanInvestmentBankSecondTrancheMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2024-01-18 2024-01-18 0001756594 iva:FinanceContractWithEuropeanInvestmentBankFirstTrancheMember ifrs-full:FinancialLiabilitiesAtAmortisedCostMember 2024-01-01 2024-06-30 0001756594 2023-01-01 2023-12-31 0001756594 iva:HepalysPharmaIncMember 2024-06-30 0001756594 iva:HepalysPharmaIncMember 2023-12-31 0001756594 2023-12-31 0001756594 2023-01-01 2023-06-30 0001756594 iva:FibroscanMachinesMember 2024-01-01 2024-06-30 0001756594 2024-06-30 iva:item iva:entity iva:tranche iva:loan iva:agreement iva:plan iva:site iso4217:JPY xbrli:shares iva:D iso4217:EUR xbrli:shares iso4217:EUR iso4217:USD iso4217:USD iso4217:EUR iso4217:EUR xbrli:shares xbrli:pure iso4217:USD iva:employee utr:g

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

​

FORM 6-K

​

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

​

For the month of October 2024

​

Commission File Number: 001-39374

​

Inventiva S.A.

(Translation of registrant’s name into English)

​

50 rue de Dijon

21121 Daix France

+33 3 80 44 75 00

(Address of principal executive office)

​

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

​

​

​

​

On October 14, 2024, the Registrant issued the Interim Financial Report for the Six Months Ended June 30, 2024 (the “Interim Financial Report”). A copy of the Interim Financial Report is attached to this Report as exhibit 99.1.

​

EXHIBIT INDEX

​ | ​ | ​
Exhibit No. |  | Description
99.1 | ​ | Interim Financial Report
101.INS XBRL | ​ | Instance Document.
101.SCH XBRL | ​ | Taxonomy Extension Schema Document.
101.CAL XBRL | ​ | Taxonomy Extension Calculation Linkbase Document.
101.DEF XBRL | ​ | Taxonomy Extension Definition Linkbase Document.
101.IAB XBRL | ​ | Taxonomy Extension Labels Linkbase Document.
101.PRE XBRL | ​ | Taxonomy Extension Presentation Linkbase Document

​

​

​

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

​ | ​ | Inventiva S.A.
​ | ​ | (Registrant)
​ | ​ | ​
Date: October 15, 2024 | ​ | /s/ Frédéric Cren
​ | ​ | Frédéric Cren
​ | ​ | Chief Executive Officer

​

​

​

​